Loading...
Live Verdure Ltd
LV1.AX•ASX
HealthcareDrug Manufacturers - Specialty & Generic
A$0.92
A$0.00(0.00%)
Live Verdure Ltd (LV1.AX) Stock Overview
Explore Live Verdure Ltd’s financial performance, market position, analyst ratings, and future outlook.
Revenue Growth
-12.63%
↓ 12.63%
Profit Growth
A$-0.11
↓ 355.43%
EPS Growth
A$-0.11
↓ 184.24%
Operating Margin
-647.73%
↓ 332.47%
ROE
-496.41%
↓ 355.43%
Dividend Yield
0.00%
Analyst Recommendations data is not available for LV1.AXAnalyst Recommendations details for LV1.AX are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Company Profile
Live Verdure Ltd, together with its subsidiaries, engages in the development and sale of plant-based products in Australia. It offers food and nutraceutical products based on hemp seeds; and skincare products under the 13 Seeds and 8 Seeds brand names through wholesale, distribution, retail, and online channels. The company was formerly known as 13 Seeds Ltd. and changed its name to Live Verdure Limited in October 2020. Live Verdure Ltd was incorporated in 2016 and is based in Melbourne, Australia.
CEO
Mr. Gernot Kurt Abl B.Com., L.L.B.
Headquarters
459 Collins Street, Melbourne, VIC
Founded
2020